The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Archives of Clinical Neuropsychology

• Publication date

  2017-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/arclin/acx093PMID 28961692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Secondary parkinsonism.

  2020influential reference
• Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.

  2017cited by this paper
• Interventions in progressive supranuclear palsy.

  2016cited by this paper
• The Differential Diagnosis and Treatment of Atypical Parkinsonism.

  2016cited by this paper
• Managing cognition in progressive supranuclear palsy

  2016cited by this paper
• Progressive supranuclear palsy treatment—A systematic review

  2016cited by this paper
• Reduced after-effects following podokinetic adaptation in people with Parkinson's disease and freezing of gait.

  2016cited by this paper
• Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy

  2016cited by this paper
• Improving response inhibition systems in frontotemporal dementia with citalopram

  2015cited by this paper
• Current Concepts in the Treatment of Multiple System Atrophy

  2015influential reference
• Apraxia and Motor Dysfunction in Corticobasal Syndrome

  2014cited by this paper
• Diagnosis and Treatment of Corticobasal Degeneration

  2014cited by this paper
• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  2014cited by this paper
• Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group

  2014cited by this paper
• An update on the cerebellar subtype of multiple system atrophy

  2014cited by this paper
• REM sleep behaviour disorder - More than just a parasomnia.

  2013cited by this paper
• Behavioral abnormalities in progressive supranuclear palsy.

  2013cited by this paper
• Pilot study of pharmacological treatment for frontotemporal dementia: Risk of donepezil treatment for behavioral and psychological symptoms

  2013cited by this paper
• Criteria for the diagnosis of corticobasal degeneration

  2013cited by this paper
• Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management

  2013cited by this paper
• Neuropsychiatric and cognitive disorders in other parkinsonian disorders

  2013cited by this paper
• Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

  2013cited by this paper
• Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial.

  2013influential reference
• The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.

  2013cited by this paper
• Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients

  2012cited by this paper
• Cognitive testing in the diagnosis of parkinsonian disorders: A critical appraisal of the literature

  2012cited by this paper
• Frontal-Subcortical Dementias

  2012cited by this paper
• Sleep Disorders in Neurodegenerative Disorders and Stroke

  2011cited by this paper
• The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

  2011cited by this paper
• Apathy and Depression: Separate Factors in Parkinson's Disease

  2011cited by this paper
• Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).

  2011cited by this paper
• European Handbook of Neurological Management

  2011cited by this paper
• Cognition in multiple system atrophy: neuropsychological profile and interaction with mood

  2010cited by this paper
• Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

  2010cited by this paper
• Screening Instruments and Brief Batteries for Dementia

  2010cited by this paper
• Handbook of Assessment in Clinical Gerontology

  2010cited by this paper
• Does corticobasal degeneration exist? A clinicopathological re-evaluation.

  2010cited by this paper
• Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status

  2010cited by this paper
• Chapter 39. Sleep Disorders in Neurodegenerative Disorders and Stroke

  2010cited by this paper
• Pseudobulbar affect: prevalence and quality of life impact in movement disorders

  2010cited by this paper
• Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry

  2010cited by this paper
• Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.

  2010influential reference
• Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration

  2009influential reference
• [Comparison of quality of life in multiple system atrophy and Parkinson's disease].

  2009cited by this paper
• Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy

  2009cited by this paper
• Cognitive and Neuropsychiatric Profile of the Synucleinopathies: Parkinson Disease, Dementia With Lewy Bodies, and Multiple System Atrophy

  2009cited by this paper
• Assessment of dementia in patients with multiple system atrophy

  2009cited by this paper
• How do patients with parkinsonism present? A clinicopathological study

  2009cited by this paper
• Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: a prospective study.

  2009cited by this paper
• An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration

  2009influential reference
• Multiple System Atrophy and Sleep

  2008cited by this paper
• Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy.

  2008cited by this paper
• A 6‐month, open‐label study of memantine in patients with frontotemporal dementia

  2008cited by this paper
• Cognitive impairments in multiple system atrophy

  2008influential reference
• Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia

  2008influential reference
• Second consensus statement on the diagnosis of multiple system atrophy

  2008cited by this paper
• Frontal-Subcortical Dementias

  2008cited by this paper
• Current and future management of the corticobasal syndrome and corticobasal degeneration.

  2008cited by this paper
• Frontal presentation in progressive supranuclear palsy

  2007cited by this paper
• Pathological laughter and crying in patients with multiple system atrophy‐cerebellar type

  2007cited by this paper
• Cognitive and motor assessment in autopsy-proven corticobasal degeneration

  2007influential reference
• Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration.

  2007cited by this paper
• Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.

  2007cited by this paper
• Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes

  2007cited by this paper
• Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations

  2006cited by this paper
• Electroconvulsive therapy for the treatment of multiple system atrophy with major depression.

  2006cited by this paper
• Current Concepts in the Treatment

  2006influential reference
• MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.

  2006cited by this paper
• A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

  2006cited by this paper
• Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

  2006cited by this paper
• Cognitive function in multiple system atrophy of the cerebellar type

  2006cited by this paper
• Ten steps to identify atypical parkinsonism

  2006cited by this paper
• Dissociating apathy and depression in Parkinson disease

  2006cited by this paper
• What is an Atypical Parkinsonian Disorder

  2005cited by this paper
• Depressive symptoms and life satisfaction in patients with multiple system atrophy

  2005cited by this paper
• Characterizing and Assessing Speech and Language Disturbances

  2005cited by this paper
• Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD

  2005cited by this paper
• The North American Multiple System Atrophy Study Group

  2005cited by this paper
• Some aspects of the historical development of the autonomic nervous system

  2005cited by this paper
• Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration

  2005cited by this paper
• Atypical Parkinsonian Disorders – Clinical and Research Aspects

  2005cited by this paper
• Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)

  2005influential reference
• The European Multiple System Atrophy-Study Group (EMSA-SG)

  2005cited by this paper
• SSRI-Induced Apathy Syndrome: A Clinical Review

  2004cited by this paper
• Corticobasal degeneration.

  2004cited by this paper
• [Cognitive deficits in progressive supranuclear palsy].

  2003influential reference
• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  2003cited by this paper
• Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease

  2003influential reference
• The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

  2002cited by this paper
• Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.

  2002cited by this paper
• Multiple system atrophy

  2001cited by this paper
• Progressive Supranuclear Palsy

  2001cited by this paper
• The FAB: A frontal assessment battery at bedside

  2001cited by this paper
• Studies of Interference in Serial Verbal Reactions

  2001cited by this paper
• Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

  2001influential reference
• Depression in multiple system atrophy: A case report

  2000cited by this paper
• A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia

  2000cited by this paper
• Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy

  2000cited by this paper
• The FAB: A frontal assessment battery at bedside

  2000cited by this paper

• Atypical Parkinsonian Disorders.

  2025cites this paper
• Updates on the neuropsychological evaluation of movement disorders

  2025cites this paper
• Pathomechanisms of neuropsychiatric disturbances in atypical parkinsonian disorders: a current view

  2025cites this paper
• Verbal fluency is associated with Gait impairment in Progressive Supranuclear Palsy

  2025cites this paper
• Impulse Control Disorders in Parkinson’s Disease and Atypical Parkinsonian Syndromes—Is There a Difference?

  2024cites this paper
• Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect

  2024cites this paper
• Relationships between Serum Lipid, Uric Acid Levels and Mild Cognitive Impairment in Parkinson's Disease and Multiple System Atrophy.

  2024cites this paper
• The Pathobiology of Behavioral Changes in Multiple System Atrophy: An Update

  2024cites this paper
• Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test

  2022influential citation
• Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6

  2022influential citation
• Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study

  2022cites this paper
• Cognitive Syndromes Associated With Movement Disorders

  2022cites this paper
• The alphasynucleinopathies: Parkinson’s disease, Lewy body dementia, and multisystem atrophy

  2021cites this paper
• Corticobasal syndrome: a practical guide

  2021cites this paper
• Co‐Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy

  2021cites this paper
• Answers to Exercises

  2020cites this paper
• Parkinson’s Disease Dementia

  2020cites this paper
• Vascular Dementia

  2020cites this paper
• Huntington’s Disease

  2020cites this paper
• Language in Dementia

  2020cites this paper
• Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.

  2020cites this paper
• Alzheimer’s Dementia

  2020cites this paper
• Bibliography

  2020cites this paper
• Preface

  2020cites this paper
• Index

  2020cites this paper
• Glossary

  2020cites this paper
• Test Protocol

  2020cites this paper
• Test Material

  2020cites this paper
• Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.

  2019cites this paper
• The Progressive Supranuclear Palsy: Past and Present Aspects

  2019influential citation
• Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson’s disease

  2019influential citation
• Motor, cognitive and behavioral differences in MDS PSP phenotypes

  2019cites this paper
• Progressive Supranuclear Palsy

  2018cites this paper
• Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy

  2018cites this paper
• Atypical Initial Presentation of Painful Muscle Cramps in a Patient with Amyotrophic Lateral Sclerosis: A Case Report and Brief Review of the Literature

  2017cites this paper
• Progressive supranuclear palsy

  2015cites this paper
• Mild Cognitive Impairment

  2008cites this paper